BECN1 and pancreatic neoplasm: Bax can directly inhibit autophagy (134), and treatment of pancreatic cancer cells with 4-AAQB enhances the expression of pro-apoptotic protein Bax and reduces the expression levels of autophagy-related proteins (Atg5, Beclin-1, and LC3 II).